Our study observed a moderate negative association between PD-L1 and CD8+ TILs, which suggested that intrinsic pathways might prevail over inflammatory signals, drive PD-L1 overexpression and block tumor immunity in early ESCC. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.